BioLargo Subsidiary Clyra Medical Technologies Adds Two Medical Industry Veterans to its Board of Directors
WESTMINSTER, CA / ACCESSWIRE / February 20, 2023 / BioLargo, Inc. (OTCQB:BLGO), a developer of
Veterans
Corium Pharma Solutions Names Two Industry Veterans to its Executive Team

 
 
 Appointments of Kevin Ostrander to Main Enterprise Officer and Dr. Niraj